Atlas Trials

Qifeng Zhang

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Qifeng Zhang

RecordFirmDate
Evaluate the Effectiveness and Safety of BBD-1 Multi-target Immune Enhancement Targeting Agent in the Treatment of Hypersensitivity Reaction (IgA) Vasculitis (NCT07595367)Qifeng Zhang2026-08-10

Track Qifeng Zhang automatically

Every clearance here is in the API, with alerts when new ones post.